AUSTIN (KXAN) — A new technology is giving doctors a non-invasive method for treating liver cancer, without requiring incisions or surgery. Histotripsy uses ultrasound waves to create tiny air bubbles ...
Histotripsy is a non-invasive treatment, approved by the Food and Drug Administration (FDA) in 2023, that uses ultrasound energy to destroy liver tumors in a single outpatient procedure. This includes ...
(RTTNews) - Exact Sciences Corp. (EXAS), Friday announced the landmark clinical results from its ALTUS study, showing that the Oncoguard Liver blood test significantly outperforms ultrasound in ...
Two new clinical trials show that microbubble ultrasound contrast agents safely and effectively improve liver tumor responses to radiotherapy and patient survival, according to results announced today ...
Ochsner MD Anderson Cancer Center at The Gayle and Tom Benson Cancer Center in New Orleans is now offering histotripsy, a non ...
ALTUS study is the largest prospective trial of a blood test for liver cancer surveillance in the United States, reflecting the racial and ethnic diversity of high-risk groups Exact Sciences Corp.
As areas of uncontrolled cell growth, cancerous growth form a major problem for a multi-celled organism like us humans. Thus ...
Liver cancer remains one of the deadliest cancers worldwide, something that escapes early detection. Understand liver cancer, ...
The liver is an extremely sensitive organ. It filters blood, eliminates toxins and creates bile to digest food; without a functioning liver, a person will die. Its sensitive nature, however, makes it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback